Background: HIV testing is crucial in identifying and initiating the treatment of HIV/AIDS. In recent years, the Oral Rapid Tests (ORT) has become one of the most popular tests based on saliva. This paper aims to present the response from research subjects who took the ORT using OraQuick®. Discussion: A total of 2657 studies was obtained. Finally, 21 articles matched to our review. The 21 included studies showed the advantages of ORT such as comfortable 91%, easy to use 76%, quick results 54%, preferred choice 67%, maintains confidentiality 54% and other reasons. Our reviewed studies demonstrated the consistent high acceptability of the oral rapid test in HIV. Conclusion: The comforts stem from ORT with OraQuick® are being contributed by its easy to use characteristic and non-blood-withdrawn comfortable method
INTRODUCTION
In 2017, globally people living with HIV reached 36.9 million.
1 Strategies to combat HIV/AIDS are based on early detection of HIV infection and appropriate treatment planning. In general conventional strategy for HIV testing is the use of the specific antibody screening such as the ELISA test. 1, 2, 3 This cannot always be done in a developing country because it requires expensive customized laboratory equipment with expert staffs. 2, 4 Also those who are at high risk of HIV infection are sometimes constrained in the process of blood-taking due to perceived pain from the injection.
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In 2004, a rapid HIV-antibody-based test named OraQuick® advance rapid HIV-1/2 (OraSure Technologies Inc, PA, USA) was approved by the US Food and Drug Administration (FDA) to use with specimens of oral mucosal transudate. 6 In recent years, ORT has become one of the most popular saliva-based tests. It is more acceptable to most patients because of the non-invasive specimen collection, quick result, and ease of use. 7, 8 Some even promoted the OraQuick® for a home self-testing of HIV. 6, 9 Unfortunately in Indonesia, ORT is highly unpopular and in general is a strange concept for medical and dental practitioners even though the ORT is more appealing to invite people to screen for early HIV infection. Especially in areas that are difficult to reach and laboratory facilities are not available. This study aims to present the advantages of ORT using OraQuick® to serve as a supporting literature in the use of OraQuick® for the dental practitioner.
LITERATURE REVIEW
The literature was conducted according to the Preferred Reporting Items For Systematic Reviews and Meta-Analyses Protocols (PRIS-MA-P) 2015 statement. Inclusion criteria. Full-text articles were included regardless of the time period of study and year of publication.
The studies included had to be an original article published in scientific journals, randomized control trial, cross-sectional or cohort studies, comparative studies, only humans and written in the English language.Individuals with HIV infection or not. No restriction for HIV diagnosis classification criteria was applied.
We expect this ORT to become a new breakthrough as technology develops as an HIV fast test that is accurate and in great demand by the public.
Exclusions criteria. The quality of journals that are not included in the Scopus index and the case report studies. Literature presented outside of English was also excluded from this study.
The quality of the reference from this study uses Scopus with results consisting of Q1 in 15 studies, Q2 in 4 studies, and Q3 in 2 studies. Follow the procedures according to Joanna Briggs Institue (JBI) to see the bias from the reviewed literature. 11 In determining the results of this study, we categorize groups based on their respective types of research. The outcome of the preferred Oral Rapid Test HIV from the included studies was presented as a percentage displayed in the form of tables (Table 3) .
The search strategy resulted in 2657 articles, which then filtered to finally got 21 publications that were eligible for our review ( Figure  1) . We reviewed the quality of these 21 studies, 15 studies were in quartile 1 (Q1), 4 research on Q2, and 2 research on Q3 (Table 1) .
There are 14 cross-sectional and 5 research testing, should sold in public, recommended to use for community, importance, willingness to pay and benefited (Table 3) .
The use of this device is only in developing countries. The absence of calibration of this tool by default and according to evidence-based medicine.
There is a possibility of literature in other languages than English that discusses the same topic as this paper. This paper also collects data from various developing countries with high risk prevalence and does not cover all countries including Indonesia.
DISCUSSION
ORT is the latest technological breakthrough that has been internationally recognized and has been approved by the USA FDA. 33 Where the accuracy has been tested and carried out by various developing countries with the results of sensitivity and specificity that are almost equal to conventional tests such as ELISA.
6,34
Some of this research was carried out on populations at high risk of HIV and also pregnant women because it is very high risk to transmit infection to surrounding communities, Tabel 2. The population and type of research studies Tabel 3. Results of selected studies according to the outcome review especially in pregnant women who will transmit to the babies they conceive as the results of research conducted by Pant Pai et al in India, where the author stated the importance of screening HIV tests on pregnant women as the last chance to prevention of mother-to-child HIV transmission (PMTCT), especially in settings where women do not receive adequate antenatal care. 35 Of all the studies both analytic and descriptive studies that have been conducted in several countries, participants generally prefer HIV screening with oral rapid test compared to conventional tests. 12, 13, 18 The main reason for the participants is due to the absence of pain from the blood-taking activity.
14,15 Conventional HIV testing is done by taking blood samples which will be seen are HIV antibodies that can also be found in saliva. This is very helpful especially for people who are afraid of needles and do not want to be hurt by taking blood. Similar with results of the studies by Zachary et al which experience, oral fluid-based testing offers many advantages over blood-based testing, especially with self-testing on the horizon.
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The result is faster just waiting for about 20 minutes which we can see in the research results in the table above. 27, 37, 38 This tool is known as lateral flow immunoassays, which essentially coax analytes (HIV antibodies, in this case) up from cotton or the tip and into the yield area. Once they're in that area, two wall-like strips called membranes capture the analyte and show up as colored lines. 6, 38 This HIV antibody test detects cells created by the immune system (defense) in response to HIV infection. Most HIV tests detect the presence of HIV antibodies, not the HIV virus. 6, 37 This tool just enough to swabbing it between the gums and teeth. 6, 37 The potential benefits of HIV self-testing include increased access to testing and early diagnosis for people living with HIV. 39, 40 People who do self-tests also experience greater comfort, autonomy, and privacy when testing, and this is possible provides options for individuals who do not use existing HTC services or those who do not have regular contact with (or access to) health services where HIV testing is offered. 37, 39 This ORT can be used privately at home so it is more appropriate for use by populations with high HIV prevalence. Thus, it is easier to access especially health workers in minimizing the impact of the increasing incidence of HIV infection in a region.
So far there are no risks associated with the use of ORT, there are no adverse events or hazards has been reported to date (for example there are no human rights violations from HIV self-testing abuse, or no reports of violence or self-harm.
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The oral fluid HIV test is very accurate. This test is FDA-approved with> 99% sensitivity and specificity claimed in many types of specimens, including oral fluids. In several studies, the OraQuick® In-Home HIV Test detected more than 91.7 percent of people infected with HIV, and 99.9 percent of people who were not infected with HIV. 6, 37, 41, 42 In 2016, approximately 102 million HIV RDTs for professional use were reportedly procedure by the Global Fund, PEPFAR, UNICEF, and WHO. On June 27, 2017, the Charity Support Agreement between Bill&Melinda Gates
The Foundation an OraSure Technologies Inc. were announced to reduce OraQuick® costs HIV Self-Test for public sector buyers in 50 low-income / heavy-burden countries. Funding to activate a more affordable price ($ 2.00 ex-works) will consist of related support payments volume of products sold and reimbursement of certain related costs.
This test will also detect samples with predominantly IgM reactivity. The report of studies by Guillon et al detect IgM antibodies during an acute infection window period of approximately 20-25 days after infection. 6 
CONCLUSIONS
We concluded that high acceptance of Oral Rapid Test HIV, which in addition to easy, quick results and comfortable, also has high accuracy to match other conventional tests. Countries should make Oral Rapid Test as the HIVST available and determine over the counter for strategies to facilitate linkage, cost-effectiveness, and the pathway to create supportive policies will be needed to maximize the potential of introducing HIVST.
